{"id":28093,"date":"2020-06-20T17:14:46","date_gmt":"2020-06-20T11:44:46","guid":{"rendered":"https:\/\/kashmir.today\/?p=28093"},"modified":"2020-06-20T17:14:46","modified_gmt":"2020-06-20T11:44:46","slug":"an-indian-drug-company-glenmark-launches-covid-19-drug-after-drugs-controller-general-of-india-nod","status":"publish","type":"post","link":"https:\/\/kashmir.watch\/?p=28093","title":{"rendered":"An Indian Drug Company Glenmark launches COVID-19 drug after Drugs Controller General of India nod"},"content":{"rendered":"\n<p class=\"has-text-align-center wp-block-paragraph\"><img decoding=\"async\" src=\"\"><img decoding=\"async\" srcset=\"https:\/\/m-economictimes-com.cdn.ampproject.org\/ii\/w680\/s\/m.economictimes.com\/thumb\/height-450,width-600,imgsize-263133,msid-73494860\/glenmark.jpg 680w, https:\/\/m-economictimes-com.cdn.ampproject.org\/ii\/w820\/s\/m.economictimes.com\/thumb\/height-450,width-600,imgsize-263133,msid-73494860\/glenmark.jpg 820w\" src=\"https:\/\/m-economictimes-com.cdn.ampproject.org\/i\/s\/m.economictimes.com\/thumb\/height-450,width-600,imgsize-263133,msid-73494860\/glenmark.jpg\" alt=\"\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement.<\/p>\n\n\n\n\n\n<p class=\"wp-block-paragraph\">The drug will be available as a prescription-based medication for Rs 103\/tablet, with recommended dose being 1,800 mg twice on day one, followed by 800 mg twice daily up to day 14.<\/p>\n\n\n\n<figure class=\"wp-block-embed-twitter aligncenter wp-block-embed is-type-rich is-provider-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19\u00a0. <a href=\"https:\/\/t.co\/tcOFxNWwWL\">pic.twitter.com\/tcOFxNWwWL<\/a><\/p>&mdash; Ashish Chaturvedi (@AshishZBiz) <a href=\"https:\/\/twitter.com\/AshishZBiz\/status\/1274253051092590592?ref_src=twsrc%5Etfw\">June 20, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms<\/em>.<\/p>\n\n\n\n\n\n<p class=\"wp-block-paragraph\">It offers rapid reduction in viral load within four days and provides faster symptomatic and radiological improvement, the drug maker added.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement. The drug will be available as a prescription-based medication for Rs 103\/tablet, with recommended dose being 1,800 mg twice on day one, followed by 800 mg twice daily up to day 14. Favipiravir can be used for [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":24429,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-28093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national"],"_links":{"self":[{"href":"https:\/\/kashmir.watch\/index.php?rest_route=\/wp\/v2\/posts\/28093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kashmir.watch\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kashmir.watch\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kashmir.watch\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kashmir.watch\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28093"}],"version-history":[{"count":0,"href":"https:\/\/kashmir.watch\/index.php?rest_route=\/wp\/v2\/posts\/28093\/revisions"}],"wp:attachment":[{"href":"https:\/\/kashmir.watch\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kashmir.watch\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kashmir.watch\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}